Thanks stonemason. The repair option cardiocel gives will also take market share from Medtronic and the others. After watching the interviews with the worlds leading surgeons from the eacts it seems the world leading valve specialists prefer repair as first choice treatment. The TAVI valves being used at the moment by Edwards and Medtronic are very new with only 2or 3 years data and as the use bovine pericardium these surgeons are expecting problems after 5-6 years and are wary of them. My hunch is the bovine or porcine valves treated with adapt will be the next line of action if repair is impossible as a replacement valve. But this is a year or two away by the looks.
- Forums
- ASX - By Stock
- 12 Months To Look Forward To…...
Thanks stonemason. The repair option cardiocel gives will also...
-
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M |
Open | High | Low | Value | Volume |
$18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 109 | $18.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.10 | 700 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 48 | 17.750 |
1 | 26 | 17.650 |
1 | 200 | 17.560 |
1 | 500 | 17.550 |
1 | 1 | 17.510 |
Price($) | Vol. | No. |
---|---|---|
18.100 | 700 | 1 |
18.300 | 150 | 1 |
18.500 | 43 | 1 |
18.690 | 550 | 1 |
18.750 | 143 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |